{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:57:03Z","timestamp":1795064223514,"version":"4.10.2"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>After acute lesions in the central nervous system (CNS), the interaction of microglia, astrocytes, and infiltrating immune cells decides over their resolution or chronification. However, this CNS-intrinsic cross-talk is poorly characterized. Analyzing cerebrospinal fluid (CSF) samples of Multiple Sclerosis (MS) patients as well as CNS samples of female mice with experimental autoimmune encephalomyelitis (EAE), the animal model of MS, we identify microglia-derived TGF\u03b1 as key factor driving recovery. Through mechanistic in vitro studies, in vivo treatment paradigms, scRNA sequencing, CRISPR-Cas9 genetic perturbation models and MRI in the EAE model, we show that together with other glial and non-glial cells, microglia secrete TGF\u03b1 in a highly regulated temporospatial manner in EAE. Here, TGF\u03b1 contributes to recovery by decreasing infiltrating T cells, pro-inflammatory myeloid cells, oligodendrocyte loss, demyelination, axonal damage and neuron loss even at late disease stages. In a therapeutic approach in EAE, blood-brain barrier penetrating intranasal application of TGF\u03b1 attenuates pro-inflammatory signaling in astrocytes and CNS infiltrating immune cells while promoting neuronal survival and lesion resolution. Together, microglia-derived TGF\u03b1 is an important mediator of glial-immune crosstalk, highlighting its therapeutic potential in resolving acute CNS inflammation.<\/jats:p>","DOI":"10.1038\/s41467-025-60363-7","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T05:10:46Z","timestamp":1750309846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["TGF\u03b1 controls checkpoints in CNS resident and infiltrating immune cells to promote resolution of inflammation"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5705-9175","authenticated-orcid":false,"given":"Lena","family":"L\u00f6\u00dflein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5528-5141","authenticated-orcid":false,"given":"Mathias","family":"Linnerbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finnja","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7889-1256","authenticated-orcid":false,"given":"Thanos","family":"Tsaktanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Vandrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Panier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Zissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivienne","family":"Riekher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"B\u00e4uerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5416-7752","authenticated-orcid":false,"given":"Jannis","family":"Hanspach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik B.","family":"Laun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"M\u00e9sz\u00e1ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0408-6388","authenticated-orcid":false,"given":"Friederike","family":"Zunke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0630-9204","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike J.","family":"Naumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Schwingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emely","family":"Neumaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9069-2594","authenticated-orcid":false,"given":"Arthur","family":"Liesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8156-0736","authenticated-orcid":false,"given":"Francisco","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0296-843X","authenticated-orcid":false,"given":"Veit","family":"Rothhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"60363_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41580-022-00562-y","volume":"24","author":"B Zheng","year":"2023","unstructured":"Zheng, B. & Tuszynski, M. H. Regulation of axonal regeneration after mammalian spinal cord injury. Nat. Rev. Mol. Cell Biol. 24, 396\u2013413 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"60363_CR2","doi-asserted-by":"crossref","unstructured":"Hussain, R., Zubair, H., Pursell, S. & Shahab, M. Neurodegenerative diseases: regenerative mechanisms and novel therapeutic approaches. Brain Sci. 8, 177 (2018).","DOI":"10.3390\/brainsci8090177"},{"key":"60363_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s41232-022-00193-y","volume":"42","author":"L Quan","year":"2022","unstructured":"Quan, L., Uyeda, A. & Muramatsu, R. Central nervous system regeneration: the roles of glial cells in the potential molecular mechanism underlying remyelination. Inflamm. Regen. 42, 7 (2022).","journal-title":"Inflamm. Regen."},{"key":"60363_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/srep04422","volume":"4","author":"MG Harris","year":"2014","unstructured":"Harris, M. G. et al. Immune privilege of the CNS is not the consequence of limited antigen sampling. Sci. Rep. 4, 4422 (2014).","journal-title":"Sci. Rep."},{"key":"60363_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jns.2008.06.032","volume":"274","author":"E Meinl","year":"2008","unstructured":"Meinl, E., Krumbholz, M., Derfuss, T., Junker, A. & Hohlfeld, R. Compartmentalization of inflammation in the CNS: A major mechanism driving progressive multiple sclerosis. J. Neurol. Sci. 274, 42\u201344 (2008).","journal-title":"J. Neurol. Sci."},{"key":"60363_CR6","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/brain\/awy151","volume":"141","author":"J Machado-Santos","year":"2018","unstructured":"Machado-Santos, J. et al. The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. Brain 141, 2066\u20132082 (2018).","journal-title":"Brain"},{"key":"60363_CR7","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3389\/fimmu.2015.00636","volume":"6","author":"L Michel","year":"2015","unstructured":"Michel, L. et al. B cells in the multiple sclerosis central nervous system: trafficking and contribution to cns-compartmentalized inflammation. Front Immunol. 6, 636 (2015).","journal-title":"Front Immunol."},{"key":"60363_CR8","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","volume":"9","author":"H Lassmann","year":"2018","unstructured":"Lassmann, H. Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Front Immunol. 9, 3116 (2018).","journal-title":"Front Immunol."},{"key":"60363_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02408-y","volume":"19","author":"E Kamma","year":"2022","unstructured":"Kamma, E., Lasisi, W., Libner, C., Ng, H. S. & Plemel, J. R. Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics. J. Neuroinflam. 19, 45 (2022).","journal-title":"J. Neuroinflam."},{"key":"60363_CR10","first-page":"527","volume":"140","author":"J Correale","year":"2017","unstructured":"Correale, J., Gait\u00e1n, M. I., Ysrraelit, M. C. & Fiol, M. P. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain 140, 527\u2013546 (2017).","journal-title":"Brain"},{"key":"60363_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann, T. et al. Multiple sclerosis progression: time for a new mechanism-driven framework.  Lancet Neurol. 22, 78\u201388 (2023).","journal-title":"Lancet Neurol."},{"key":"60363_CR12","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41582-022-00675-0","volume":"18","author":"J Oh","year":"2022","unstructured":"Oh, J. & Bar-Or, A. Emerging therapies to target CNS pathophysiology in multiple sclerosis. Nat. Rev. Neurol. 18, 466\u2013475 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"60363_CR13","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41586-018-0119-x","volume":"557","author":"V Rothhammer","year":"2018","unstructured":"Rothhammer, V. et al. Microglial control of astrocytes in response to microbial metabolites. Nature 557, 724\u2013728 (2018).","journal-title":"Nature"},{"key":"60363_CR14","doi-asserted-by":"crossref","unstructured":"Cirac, A. et al. The aryl hydrocarbon receptor-dependent TGF-\u03b1\/VEGF-B ratio correlates with disease subtype and prognosis in multiple sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 8, e1043 (2021).","DOI":"10.1212\/NXI.0000000000001043"},{"key":"60363_CR15","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1523\/JNEUROSCI.12-05-01688.1992","volume":"12","author":"LM Lazar","year":"1992","unstructured":"Lazar, L. M. & Blum, M. Regional distribution and developmental expression of epidermal growth factor and transforming growth factor-alpha mRNA in mouse brain by a quantitative nuclease protection assay. J. Neurosci. 12, 1688\u20131697 (1992).","journal-title":"J. Neurosci."},{"key":"60363_CR16","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.6320373","volume":"223","author":"H Marquardt","year":"1984","unstructured":"Marquardt, H., Hunkapiller, M. W., Hood, L. E. & Todaro, G. J. Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science 223, 1079\u20131082 (1984).","journal-title":"Science"},{"key":"60363_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1523\/JNEUROSCI.12-02-00583.1992","volume":"12","author":"A Chalazonitis","year":"1992","unstructured":"Chalazonitis, A., Kessler, J. A., Twardzik, D. R. & Morrison, R. S. Transforming growth factor alpha, but not epidermal growth factor, promotes the survival of sensory neurons in vitro. J. Neurosci. 12, 583\u2013594 (1992).","journal-title":"J. Neurosci."},{"key":"60363_CR18","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.1523\/JNEUROSCI.21-18-07079.2001","volume":"21","author":"S Boill\u00e9e","year":"2001","unstructured":"Boill\u00e9e, S., Cadusseau, J., Coulpier, M., Grannec, G. & Junier, M.-P. Transforming growth factor \u03b1: a promoter of motoneuron survival of potential biological relevance.  J. Neurosci. 21, 7079\u20137088 (2001).","journal-title":"J. Neurosci."},{"key":"60363_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-020-1999-0","volume":"578","author":"MA Wheeler","year":"2020","unstructured":"Wheeler, M. A. et al. MAFG-driven astrocytes promote CNS inflammation. Nature 578, 593\u2013599 (2020).","journal-title":"Nature"},{"key":"60363_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08446-0","volume":"10","author":"V Bellver-Landete","year":"2019","unstructured":"Bellver-Landete, V. et al. Microglia are an essential component of the neuroprotective scar that forms after spinal cord injury. Nat. Commun. 10, 518 (2019).","journal-title":"Nat. Commun."},{"key":"60363_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/nbm.1229","volume":"21","author":"MD Budde","year":"2008","unstructured":"Budde, M. D. et al. Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. NMR Biomed. 21, 589\u2013597 (2008).","journal-title":"NMR Biomed."},{"key":"60363_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/joim.13215","volume":"289","author":"F Piehl","year":"2021","unstructured":"Piehl, F. Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis. J. Intern. Med. 289, 771\u2013791 (2021).","journal-title":"J. Intern. Med."},{"key":"60363_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1001\/jama.2018.20588","volume":"321","author":"JWL Brown","year":"2019","unstructured":"Brown, J. W. L. et al. Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis. JAMA 321, 175\u2013187 (2019).","journal-title":"JAMA"},{"key":"60363_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13052-018-0563-0","volume":"44","author":"CM Bellettato","year":"2018","unstructured":"Bellettato, C. M. & Scarpa, M. Possible strategies to cross the blood-brain barrier. Ital. J. Pediatr. 44, 131 (2018).","journal-title":"Ital. J. Pediatr."},{"key":"60363_CR25","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.4106","volume":"22","author":"V Rothhammer","year":"2016","unstructured":"Rothhammer, V. et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med 22, 586\u2013597 (2016).","journal-title":"Nat. Med"},{"key":"60363_CR26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41590-024-01756-6","volume":"25","author":"M Linnerbauer","year":"2024","unstructured":"Linnerbauer, M. et al. The astrocyte-produced growth factor HB-EGF limits autoimmune CNS pathology. Nat. Immunol. 25, 432\u2013447 (2024).","journal-title":"Nat. Immunol."},{"key":"60363_CR27","doi-asserted-by":"crossref","unstructured":"Lim, D. et al. Anti-tumor activity of an immunotoxin (TGF\u03b1-PE38) delivered by attenuated Salmonella typhimurium. Oncotarget 8, 37550\u201337560 (2017).","DOI":"10.18632\/oncotarget.17197"},{"key":"60363_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0301-0082(00)00017-4","volume":"62","author":"MP Junier","year":"2000","unstructured":"Junier, M. P. What role(s) for TGFalpha in the central nervous system?. Prog. Neurobiol. 62, 443\u2013473 (2000).","journal-title":"Prog. Neurobiol."},{"key":"60363_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neuroscience.2009.05.050","volume":"163","author":"RR Leker","year":"2009","unstructured":"Leker, R. R. et al. Transforming growth factor alpha induces angiogenesis and neurogenesis following stroke. Neuroscience 163, 233\u2013243 (2009).","journal-title":"Neuroscience"},{"key":"60363_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.expneurol.2008.06.012","volume":"214","author":"RE White","year":"2008","unstructured":"White, R. E., Yin, F. Q. & Jakeman, L. B. TGF-alpha increases astrocyte invasion and promotes axonal growth into the lesion following spinal cord injury in mice. Exp. Neurol. 214, 10\u201324 (2008).","journal-title":"Exp. Neurol."},{"key":"60363_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.09.005","volume":"19","author":"M Guerra-Crespo","year":"2010","unstructured":"Guerra-Crespo, M., Sistos, A., Gleason, D. & Fallon, J. H. Intranasal administration of PEGylated transforming growth factor-alpha improves behavioral deficits in a chronic stroke model. J. Stroke Cerebrovasc. Dis. 19, 3\u20139 (2010).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"60363_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nature17623","volume":"532","author":"MA Anderson","year":"2016","unstructured":"Anderson, M. A. et al. Astrocyte scar formation aids central nervous system axon regeneration. Nature 532, 195\u2013200 (2016).","journal-title":"Nature"},{"key":"60363_CR33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","volume":"14","author":"B Hemmer","year":"2015","unstructured":"Hemmer, B., Kerschensteiner, M. & Korn, T. Role of the innate and adaptive immune responses in the course of multiple sclerosis.  Lancet Neurol. 14, 406\u2013419 (2015).","journal-title":"Lancet Neurol."},{"key":"60363_CR34","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(16)31320-4","volume":"389","author":"D Ontaneda","year":"2017","unstructured":"Ontaneda, D., Thompson, A. J., Fox, R. J. & Cohen, J. A. Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function.  Lancet 389, 1357\u20131366 (2017).","journal-title":"Lancet"},{"key":"60363_CR35","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1172\/JCI74255","volume":"125","author":"L Steinman","year":"2015","unstructured":"Steinman, L. No quiet surrender: molecular guardians in multiple sclerosis brain. J. Clin. Invest. 125, 1371\u20131378 (2015).","journal-title":"J. Clin. Invest."},{"key":"60363_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0014-4827(02)00098-8","volume":"284","author":"RN Jorissen","year":"2003","unstructured":"Jorissen, R. N. et al. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res. 284, 31\u201353 (2003).","journal-title":"Exp. Cell Res."},{"key":"60363_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.phrs.2013.11.002","volume":"79","author":"R Roskoski Jr","year":"2014","unstructured":"Roskoski, R. Jr The ErbB\/HER family of protein-tyrosine kinases and cancer. Pharm. Res. 79, 34\u201374 (2014).","journal-title":"Pharm. Res."},{"key":"60363_CR38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1091\/mbc.2.8.599","volume":"2","author":"R Ebner","year":"1991","unstructured":"Ebner, R. & Derynck, R. Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes. Cell Regul. 2, 599\u2013612 (1991).","journal-title":"Cell Regul."},{"key":"60363_CR39","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1074\/jbc.270.9.4334","volume":"270","author":"AR French","year":"1995","unstructured":"French, A. R., Tadaki, D. K., Niyogi, S. K. & Lauffenburger, D. A. Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor\/ligand interaction. J. Biol. Chem. 270, 4334\u20134340 (1995).","journal-title":"J. Biol. Chem."},{"key":"60363_CR40","doi-asserted-by":"publisher","first-page":"8374","DOI":"10.1073\/pnas.82.24.8374","volume":"82","author":"AJ Clark","year":"1985","unstructured":"Clark, A. J., Ishii, S., Richert, N., Merlino, G. T. & Pastan, I. Epidermal growth factor regulates the expression of its own receptor. Proc. Natl. Acad. Sci. USA 82, 8374\u20138378 (1985).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"60363_CR41","doi-asserted-by":"publisher","first-page":"120082","DOI":"10.1016\/j.ijpharm.2020.120082","volume":"592","author":"EDS Santos","year":"2021","unstructured":"Santos, E. D. S. et al. EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles. Int. J. Pharmaceutics 592, 120082 (2021).","journal-title":"Int. J. Pharmaceutics"},{"key":"60363_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.nbd.2016.01.010","volume":"88","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system. Neurobiol. Dis. 88, 85\u201395 (2016).","journal-title":"Neurobiol. Dis."},{"key":"60363_CR43","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1177\/0271678X19830791","volume":"40","author":"X Dai","year":"2020","unstructured":"Dai, X. et al. TGFalpha preserves oligodendrocyte lineage cells and improves white matter integrity after cerebral ischemia. J. Cereb. Blood Flow. Metab. 40, 639\u2013655 (2020).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"60363_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden, Y. & Sliwkowski, M. X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2, 127\u2013137 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"60363_CR45","doi-asserted-by":"crossref","unstructured":"Filep, J. G. Targeting neutrophils for promoting the resolution of inflammation. Front. Immunol. 13, 866747 (2022).","DOI":"10.3389\/fimmu.2022.866747"},{"key":"60363_CR46","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera, A., Soehnlein, O. & Kenne, E. Neutrophils in chronic inflammatory diseases. Cell. Mol. Immunol. 19, 177\u2013191 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"60363_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.smim.2016.03.007","volume":"28","author":"HR Jones","year":"2016","unstructured":"Jones, H. R., Robb, C. T., Perretti, M. & Rossi, A. G. The role of neutrophils in inflammation resolution. Semin. Immunol. 28, 137\u2013145 (2016).","journal-title":"Semin. Immunol."},{"key":"60363_CR48","doi-asserted-by":"crossref","unstructured":"Walters, N. et al. Analyzing inter-leukocyte communication and migration in vitro: neutrophils play an essential role in monocyte activation during swarming. Front. Immunol. 12, 866747 (2021).","DOI":"10.3389\/fimmu.2021.671546"},{"key":"60363_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jneuroim.2006.11.015","volume":"184","author":"LK Peterson","year":"2007","unstructured":"Peterson, L. K. & Fujinami, R. S. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J. Neuroimmunol. 184, 37\u201344 (2007).","journal-title":"J. Neuroimmunol."},{"key":"60363_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.12703\/P5-20","volume":"5","author":"PK Stys","year":"2013","unstructured":"Stys, P. K. Pathoetiology of multiple sclerosis: are we barking up the wrong tree?. F1000Prime Rep. 5, 20 (2013).","journal-title":"F1000Prime Rep."},{"key":"60363_CR51","doi-asserted-by":"crossref","unstructured":"Ciccone, A. et al. Corticosteroids for the long-term treatment in multiple sclerosis. Cochrane Database Syst. Rev. Cd006264 (2008).","DOI":"10.1002\/14651858.CD006264.pub2"},{"key":"60363_CR52","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1167\/iovs.09-4009","volume":"51","author":"M Dutt","year":"2010","unstructured":"Dutt, M., Tabuena, P., Ventura, E., Rostami, A. & Shindler, K. S. Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis. Invest. Ophthalmol. Vis. Sci. 51, 1439\u20131445 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"60363_CR53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","volume":"53","author":"S-H Jeong","year":"2023","unstructured":"Jeong, S.-H., Jang, J.-H. & Lee, Y.-B. Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. J. Pharm. Investig. 53, 119\u2013152 (2023).","journal-title":"J. Pharm. Investig."},{"key":"60363_CR54","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1183\/09031936.03.00014703","volume":"22","author":"A Bergeron","year":"2003","unstructured":"Bergeron, A. et al. Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10.  Eur. Resp. J. 22, 69\u201376 (2003).","journal-title":"Eur. Resp. J."},{"key":"60363_CR55","doi-asserted-by":"publisher","first-page":"L1046","DOI":"10.1152\/ajplung.00045.2003","volume":"285","author":"TD Le Cras","year":"2003","unstructured":"Le Cras, T. D., Hardie, W. D., Fagan, K., Whitsett, J. A. & Korfhagen, T. R. Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-alpha. Am. J. Physiol. Lung Cell. Mol. Physiol. 285, L1046\u2013L1054 (2003).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"60363_CR56","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1513\/pats.201203-023AW","volume":"9","author":"IE Fernandez","year":"2012","unstructured":"Fernandez, I. E. & Eickelberg, O. The impact of TGF-\u03b2 on lung fibrosis: from targeting to biomarkers. Proc. Am. Thorac. Soc. 9, 111\u2013116 (2012).","journal-title":"Proc. Am. Thorac. Soc."},{"key":"60363_CR57","doi-asserted-by":"crossref","unstructured":"Chen, B., Mu, C., Zhang, Z., He, X. & Liu, X. The love-hate relationship between TGF-\u03b2 signaling and the immune system during development and tumorigenesis. Front. Immunol. 13, 891268 (2022).","DOI":"10.3389\/fimmu.2022.891268"},{"key":"60363_CR58","doi-asserted-by":"crossref","unstructured":"Chen, P.-Y., Qin, L. & Simons, M. TGF\u03b2 signaling pathways in human health and disease. Front. Mol. Biosci. 10, 1113061 (2023).","DOI":"10.3389\/fmolb.2023.1113061"},{"key":"60363_CR59","first-page":"157","volume":"43","author":"P Locci","year":"1999","unstructured":"Locci, P. et al. TGFbeta and TGFalpha, antagonistic effect in vitro on extracellular matrix accumulation by chick skin fibroblasts at two distinct embryonic stages.  Int. J. Dev. Biol. 43, 157\u2013165 (1999).","journal-title":"Int. J. Dev. Biol."},{"key":"60363_CR60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000334891","volume":"97","author":"M Kidd","year":"2013","unstructured":"Kidd, M., Schimmack, S., Lawrence, B., Alaimo, D. & Modlin, I. M. EGFR\/TGF\u03b1 and TGF\u03b2\/CTGF signaling in neuroendocrine neoplasia: theoretical therapeutic targets. Neuroendocrinology 97, 35\u201344 (2013).","journal-title":"Neuroendocrinology"},{"key":"60363_CR61","doi-asserted-by":"publisher","first-page":"e41869","DOI":"10.7554\/eLife.41869","volume":"8","author":"M Hamaguchi","year":"2019","unstructured":"Hamaguchi, M. et al. Circulating transforming growth factor-\u03b21 facilitates remyelination in the adult central nervous system. eLife 8, e41869 (2019).","journal-title":"eLife"},{"key":"60363_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06224-y","volume":"9","author":"T Z\u00f6ller","year":"2018","unstructured":"Z\u00f6ller, T. et al. Silencing of TGF\u03b2 signalling in microglia results in impaired homeostasis. Nat. Commun. 9, 4011 (2018).","journal-title":"Nat. Commun."},{"key":"60363_CR63","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/glia.22675","volume":"62","author":"E Cekanaviciute","year":"2014","unstructured":"Cekanaviciute, E. et al. Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice. Glia 62, 1227\u20131240 (2014).","journal-title":"Glia"},{"key":"60363_CR64","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41586-019-1467-x","volume":"572","author":"N Saligrama","year":"2019","unstructured":"Saligrama, N. et al. Opposing T cell responses in experimental autoimmune encephalomyelitis. Nature 572, 481\u2013487 (2019).","journal-title":"Nature"},{"key":"60363_CR65","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-020-03116-4","volume":"590","author":"LM Sanmarco","year":"2021","unstructured":"Sanmarco, L. M. et al. Gut-licensed IFNgamma(+) NK cells drive LAMP1(+)TRAIL(+) anti-inflammatory astrocytes. Nature 590, 473\u2013479 (2021).","journal-title":"Nature"},{"key":"60363_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.800128","volume":"12","author":"M Linnerbauer","year":"2021","unstructured":"Linnerbauer, M. et al. Astrocyte-derived pleiotrophin mitigates late-stage autoimmune CNS inflammation. Front. Immunol. 12, 800128 (2021).","journal-title":"Front. Immunol."},{"key":"60363_CR67","unstructured":"Clark, I. C. et al. Barcoded viral tracing of single-cell interactions in central nervous system inflammation. Science 372, eabf1230 (2021)."},{"key":"60363_CR68","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. methods 11, 783\u2013784 (2014).","journal-title":"Nat. methods"},{"key":"60363_CR69","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.cell.2015.02.038","volume":"160","author":"S Chen","year":"2015","unstructured":"Chen, S. et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160, 1246\u20131260 (2015).","journal-title":"Cell"},{"key":"60363_CR70","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1083\/jcb.85.3.890","volume":"85","author":"KD McCarthy","year":"1980","unstructured":"McCarthy, K. D. & de Vellis, J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85, 890\u2013902 (1980).","journal-title":"J. Cell Biol."},{"key":"60363_CR71","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s42255-021-00341-7","volume":"3","author":"M Bosch-Queralt","year":"2021","unstructured":"Bosch-Queralt, M. et al. Diet-dependent regulation of TGFbeta impairs reparative innate immune responses after demyelination. Nat. Metab. 3, 211\u2013227 (2021).","journal-title":"Nat. Metab."},{"key":"60363_CR72","doi-asserted-by":"crossref","unstructured":"Linnerbauer, M. et al. Intranasal delivery of a small-molecule ErbB inhibitor promotes recovery from acute and late-stage CNS inflammation. JCI Insight 7, e154824 (2022).","DOI":"10.1172\/jci.insight.154824"},{"key":"60363_CR73","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.media.2005.04.005","volume":"9","author":"I Wolf","year":"2005","unstructured":"Wolf, I. et al. The medical imaging interaction toolkit. Med. Image Anal. 9, 594\u2013604 (2005).","journal-title":"Med. Image Anal."},{"key":"60363_CR74","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60363-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60363-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60363-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T06:02:42Z","timestamp":1750312962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60363-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60363"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60363-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"3 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5344"}}